FTY720 · CFTY720D2324
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A 32-week, multicenter, randomized, patient- and assessor-blinded, parallel-group study evaluating disease control and safety in patients with relapsing-remitting multiple sclerosis. EudraCT: 2011-001442-15.
Sponsor: NOVARTIS
Phase: III
Area: Neuroimmunology